Kawasaki-like Syndrome as an Emerging Complication of SARS-CoV-2 Infection in Young Adults
  • César Burgi Vieira
    Unidade Funcional Medicina 2.4, Centro Hospitalar Universitário de Lisboa Central, Lisboa, Portugal http://orcid.org/0000-0003-3616-5440
  • Ana Teresa Ferreira
    Unidade Funcional Medicina 4, Centro Hospitalar Universitário de Lisboa Central, Lisboa, Portugal
  • Filipa Botelho Cardoso
    Unidade Funcional Medicina 1.4, Centro Hospitalar Universitário de Lisboa Central, Lisboa, Portugal
  • Jorge Pelicano Paulos
    Departamento de Anestesiologia, Centro Hospitalar Universitário de Lisboa Central, Lisboa, Portugal
  • Nuno Germano
    Unidade de Cuidados Intensivos Polivalente 7, Centro Hospitalar Universitário de Lisboa Central, Lisboa, Portugal

Keywords

COVID-19, Kawasaki syndrome, vasculitis, adult, multisystem inflammatory syndrome

Abstract

Background: Kawasaki-like syndrome occurring in children during the COVID-19 pandemic has been labelled multisystem inflammatory syndrome in children (MIS-C) by the CDC and paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 infection (PIMS-TS) by the ECDC. 
Case report: We report the case of an 18-year-old male patient presenting with a 72-hour history of abdominal pain, fever, erythematous skin rash, vomiting and diarrhoea. Examination showed he also had shock and he was first thought to have oedematous cholecystitis. SARS-CoV-2 infection was also diagnosed. He was admitted to the ICU, and echocardiography showed cardiac dysfunction, with a low ejection fraction and low cardiac index. High-sensitivity troponin serum levels were elevated. The patient received inotropic and vasopressor support. As he fulfilled several criteria for MIS-C/PIMS-TS, he was administered acetylsalicylic acid, corticosteroids and immunoglobulin, with a good clinical response.<br />
Conclusion: This case emphasizes how this severe presentation of COVID-19 can easily be misdiagnosed if the clinician is less aware of this syndrome in younger patients.

VIEW THE ENTIRE ARTICLE

References

  • Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 2020; doi: 10.1542/peds.2020-0702.
  • Kim GB. Reality of Kawasaki disease epidemiology. Korean J Pediatr 2019;62(8):292–296.
  • De Graeff N, Groot N, Ozen S, Eleftheriou D, Avcin T, Bader-Meunier B, et al. European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative. Rheumatology (Oxford) 2019;58(4):672–682.
  • Loomba R, Villarreal E, Flores S. COVID-19 and Kawasaki syndrome: should we really be surprised? Cardiol Young 2020 May 15:1–2.
  • CDC Health Alert Network. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019. Available from: https://emergency.cdc.gov/han/2020/han00432.asp
  • European Centre for Disease Prevention and Control. Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children – 15 May 2020. ECDC: Stockholm; 2020. Available from: https://www.ecdc.europa.eu/en/publications-data/paediatric-inflammatory-multisystem-syndrome-and-sars-cov-2-rapid-risk-assessment
  • Views: 1858
    HTML downloads: 109
    PDF downloads: 676


    Published: 2020-09-10
    Issue: 2020: Vol 7 No 10 (view)


    How to cite:
    1.
    Vieira CB, Ferreira AT, Cardoso FB, Paulos JP, Germano N. Kawasaki-like Syndrome as an Emerging Complication of SARS-CoV-2 Infection in Young Adults. EJCRIM 2020;7 doi:10.12890/2020_001886.

    Most read articles by the same author(s)